CD79A and COVID-19: In adults with COVID-19, elevated levels of anti-SARS-CoV-2 IgA immune complexes are associated with severe disease28 and in children with MIS-C, anti-SARS-CoV-2 IgA immune complexes activate intravascular neutrophil extracellular traps which may contribute to endothelial damage29.